150KRW
4.67 BKRW
154.82 BKRW
25.09 M
About BINEX
Sector
CEO
Hyuk-Jong Lee
Headquarters
Busan
Website
Employees (FY)
608
Founded
1957
ISIN
KR7053030003
FIGI
BBG000C1YHY1
BINEX Co., Ltd. engages in the manufacture and sale of pharmaceuticals. It operates through the following business divisions: Bio, Pharmaceutical Manufacturing and Sales, and others. The Bio division provides bio pharmaceutical consignment production and bio analysis services. The Pharmaceutical Manufacturing and Sales division offers medicines for digesting, anti-inflammatory analagesic drug, probiotics, collyrium, antibiotics, urinary system disease, circulation disease, external ointment, antitussive expectorants, and others. The Others division provides processing services. The company was founded on December 17, 1957 and is headquartered in Busan, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 053030 is 13960 KRW — it has decreased by 4.97% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange BINEX stocks are traded under the ticker 053030.
053030 stock is 6.45% volatile and has beta coefficient of 1.83. Check out the list of the most volatile stocks — is BINEX there?
One year price forecast for BINEX has a max estimate of 12000 KRW and a min estimate of 12000 KRW.
BINEX revenue for the last quarter amounts to 31.60 B KRW despite the estimated figure of 42.70 B KRW. In the next quarter revenue is expected to reach 46.50 B KRW.
Yes, you can track BINEX financials in yearly and quarterly reports right on TradingView.
053030 stock has risen by 12.58% compared to the previous week, the month change is a 16.56% fall, over the last year BINEX has showed a 41.58% increase.
053030 net income for the last quarter is 1.74 B KRW, while the quarter before that showed −5.50 B KRW of net income which accounts for 131.72% change. Track more BINEX financial stats to get the full picture.
Today BINEX has the market capitalization of 454.28 B, it has decreased by 6.69% over the last week.
No, 053030 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 053030 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BINEX stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 608.00 employees. See our rating of the largest employees — is BINEX on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BINEX technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BINEX stock shows the buy signal. See more of BINEX technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BINEX future price: according to them, 053030 price has a max estimate of 12000.00 KRW and a min estimate of 12000.00 KRW. Read a more detailed BINEX forecast: see what analysts think of BINEX and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BINEX EBITDA is 9.80 B KRW, and current EBITDA margin is 6.43%. See more stats in BINEX financial statements.